SCHEMBL6416797

SCHEMBL6416797

COc1ccc2c(c1)C(=O)N(C)C(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2C(=O)NCC1CCNCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
TSHR P16473 2/20 0.43
POLB P06746 1/20 0.43
EPHX2 P34913 1/20 0.41
KMT2A Q03164 2/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HTR4 Q13639 1/20 0.40
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 4/20 0.39
HTT P42858 3/20 0.39
NPC1 O15118 1/20 0.39
EP300 Q09472 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
GSK3B P49841 1/20 0.38
GLA P06280 1/20 0.38
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6412309 0.88 LMNA (0.45) GAATSHRPOLBMAPK1NPSR1
SCHEMBL6410802 0.83 GAA (0.47) GAATSHRKMT2AMAPK1NPSR1
SCHEMBL6418752 0.80 NPSR1 (0.55) GAATSHRKMT2AMAPK1NPSR1
SCHEMBL6418372 0.80 LMNA (0.47) GAATSHRPOLBMAPK1NPSR1
SCHEMBL6411886 0.79 KMT2A (0.55) GAAKMT2AMAPK1NPSR1CYP3A4
SCHEMBL6418795 0.77 TSHR (0.41) TSHRPOLBKMT2AMAPK1CYP3A4
SCHEMBL6417873 0.75 MDM2 (0.51) GAAMAPK1NPSR1ALDH1A1HTT
SCHEMBL6413302 0.74 HSD17B10 (0.43) GAATSHRPOLBALDH1A1HTT
SCHEMBL6418414 0.74 ALDH1A1 (0.47) GAATSHRPOLBKMT2AMAPK1
SCHEMBL6413224 0.71 ALDH1A1 (0.60) GAATSHRPOLBNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US claimed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO claimed
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US disclosed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis CASP3, BAX, BAD GAA 2485/4885TSHR 4878/4885POLB 2345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.